CSPC Pharmaceutical Group Limited

SEHK:1093 株式レポート

時価総額:HK$73.4b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

CSPC Pharmaceutical Group 過去の業績

過去 基準チェック /26

CSPC Pharmaceutical Groupは、平均年間11.6%の収益成長を遂げていますが、 Pharmaceuticals業界の収益は、年間 成長しています。収益は、平均年間5.9% 10%収益成長率で 成長しています。 CSPC Pharmaceutical Groupの自己資本利益率は17.8%であり、純利益率は18.7%です。

主要情報

11.6%

収益成長率

11.8%

EPS成長率

Pharmaceuticals 業界の成長5.6%
収益成長率10.0%
株主資本利益率17.8%
ネット・マージン18.7%
前回の決算情報31 Mar 2024

最近の業績更新

Recent updates

Here's Why CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt Responsibly

Jun 17
Here's Why CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt Responsibly

CSPC Pharmaceutical Group Limited Just Recorded A 20% Revenue Beat: Here's What Analysts Think

May 29
CSPC Pharmaceutical Group Limited Just Recorded A 20% Revenue Beat: Here's What Analysts Think

CSPC Pharmaceutical Group (HKG:1093) Has Announced A Dividend Of CN¥0.14

May 21
CSPC Pharmaceutical Group (HKG:1093) Has Announced A Dividend Of CN¥0.14

CSPC Pharmaceutical Group (HKG:1093) Will Pay A Dividend Of CN¥0.14

Apr 29
CSPC Pharmaceutical Group (HKG:1093) Will Pay A Dividend Of CN¥0.14

There's Reason For Concern Over CSPC Pharmaceutical Group Limited's (HKG:1093) Price

Apr 22
There's Reason For Concern Over CSPC Pharmaceutical Group Limited's (HKG:1093) Price

CSPC Pharmaceutical Group's (HKG:1093) Dividend Will Be CN¥0.14

Apr 01
CSPC Pharmaceutical Group's (HKG:1093) Dividend Will Be CN¥0.14

CSPC Pharmaceutical Group Limited (HKG:1093) Shares Could Be 49% Below Their Intrinsic Value Estimate

Jan 22
CSPC Pharmaceutical Group Limited (HKG:1093) Shares Could Be 49% Below Their Intrinsic Value Estimate

Some Confidence Is Lacking In CSPC Pharmaceutical Group Limited's (HKG:1093) P/E

Jan 04
Some Confidence Is Lacking In CSPC Pharmaceutical Group Limited's (HKG:1093) P/E

Are Investors Undervaluing CSPC Pharmaceutical Group Limited (HKG:1093) By 36%?

Oct 22
Are Investors Undervaluing CSPC Pharmaceutical Group Limited (HKG:1093) By 36%?

Is CSPC Pharmaceutical Group (HKG:1093) A Risky Investment?

Sep 21
Is CSPC Pharmaceutical Group (HKG:1093) A Risky Investment?

CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 62% Above Its Share Price

Jul 09
CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 62% Above Its Share Price

Does CSPC Pharmaceutical Group (HKG:1093) Have A Healthy Balance Sheet?

Jun 20
Does CSPC Pharmaceutical Group (HKG:1093) Have A Healthy Balance Sheet?

CSPC Pharmaceutical Group's (HKG:1093) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 01
CSPC Pharmaceutical Group's (HKG:1093) Shareholders Will Receive A Bigger Dividend Than Last Year

CSPC Pharmaceutical Group (HKG:1093) Is Increasing Its Dividend To CN¥0.11

Apr 04
CSPC Pharmaceutical Group (HKG:1093) Is Increasing Its Dividend To CN¥0.11

CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 92% Above Its Share Price

Mar 12
CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 92% Above Its Share Price

We Think CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt With Ease

Dec 26
We Think CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt With Ease

CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 98% Above Its Share Price

Oct 18
CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 98% Above Its Share Price

CSPC Pharmaceutical Group (HKG:1093) Could Easily Take On More Debt

Sep 15
CSPC Pharmaceutical Group (HKG:1093) Could Easily Take On More Debt

CSPC Pharmaceutical Group (HKG:1093) Will Pay A Larger Dividend Than Last Year At CN¥0.10

Aug 26
CSPC Pharmaceutical Group (HKG:1093) Will Pay A Larger Dividend Than Last Year At CN¥0.10

収支内訳

CSPC Pharmaceutical Group の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

SEHK:1093 収益、費用、利益 ( )CNY Millions
日付収益収益G+A経費研究開発費
31 Mar 2432,3806,05710,8724,992
31 Dec 2331,4505,87310,3304,830
30 Sep 2331,3066,11810,4104,744
30 Jun 2331,4076,09210,9734,406
31 Mar 2331,1166,11611,1774,093
31 Dec 2230,9376,09111,5103,987
30 Sep 2230,7215,73811,9153,845
30 Jun 2229,6555,50911,6113,704
31 Mar 2229,0075,53811,7003,643
31 Dec 2127,8675,60511,4533,433
30 Sep 2126,3695,97710,7473,132
30 Jun 2126,1755,90810,7033,050
31 Mar 2125,5515,47210,3323,013
31 Dec 2024,9425,16010,3232,890
30 Sep 2024,5584,42110,5222,765
30 Jun 2023,5154,15010,2872,511
31 Mar 2022,7353,92210,0502,108
31 Dec 1922,1033,7149,4612,000
30 Sep 1921,3353,6258,8871,928
30 Jun 1920,1353,4548,2021,725
31 Mar 1918,8353,2947,4261,543
31 Dec 1817,7173,0816,8411,342
30 Sep 1816,8772,9056,3371,346
30 Jun 1815,7292,7345,664973
31 Mar 1813,9592,4434,839912
31 Dec 1712,8772,3074,178679
30 Sep 1712,2032,1953,747277
30 Jun 1711,6592,0683,410282
31 Mar 1711,3831,9793,2030
31 Dec 1611,0751,8812,9920
30 Sep 1610,4391,7112,7250
30 Jun 1610,1181,6072,5760
31 Mar 169,6561,4732,4190
31 Dec 159,5451,3952,3470
30 Sep 159,2841,3052,2020
30 Jun 159,0721,1922,0450
31 Mar 158,9191,1261,9380
31 Dec 148,7621,0151,8710
30 Sep 148,4238961,7480
30 Jun 148,1978491,6860
31 Mar 148,0018141,6270
31 Dec 137,7687601,5000
30 Sep 137,3451,9671,3980

質の高い収益: 1093は 高品質の収益 を持っています。

利益率の向上: 1093の現在の純利益率 (18.7%)は、昨年(19.7%)よりも低くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: 1093の収益は過去 5 年間で年間11.6%増加しました。

成長の加速: 1093は過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。

収益対業界: 1093は過去 1 年間で収益成長率がマイナス ( -1% ) となったため、 Pharmaceuticals業界平均 ( 1.3% ) と比較することが困難です。


株主資本利益率

高いROE: 1093の 自己資本利益率 ( 17.8% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘